grants_govRFA-DK-27-126
Open
Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)
- Response deadline
- Jul 1, 2026 Closed
- Date posted
- May 20, 2026
- Source
- Open notice
Description
The Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) currently supports several institutional and individual training and career development programs. The purpose of this Notice of Funding Opportunity (NOFO) is to establish a single Coordinating Center to unite and harmonize these programs, which collectively aim to recruit, train, and retain an active, national community of researchers in KUH mission areas across career stages. This highly integrated community will be called KUH-FAMILY (Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY).
Classifications
- NAICS93.847
Documents (1)
- DownloadRFA-DK-27-126-Full-Announcement.htmltext/html;charset=UTF-8135 KB
Contacts
Similar contracts
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)Due May 25, 2029
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)Due Nov 17, 2026
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)Due Jun 20, 2029
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)Due Nov 9, 2026
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Due Nov 6, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)Due Nov 9, 2026